Medicare Enrolled
Dr. Brian Kowal, M.D.
Urology Physician · Hyannis, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kowal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kowal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kowal
Dr. Brian Kowal is an urology physician in Hyannis, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kowal performed 15,875 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kowal received a total of $23,516 from 53 pharmaceutical and/or device companies across 207 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kowal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 3% volume in MA
$23,516 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗15,875
Medicare services
Top 3% in MA for urology physician
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
4,854 | $34 | $100 |
| Injection, degarelix, 1 mg | 3,600 | $3 | $12 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
1,386 | $4 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,091 | $96 | $428 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
935 | $64 | $225 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
821 | $8 | $100 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
379 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
378 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
376 | $34 | $100 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 282 | $132 | $768 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
252 | $23 | $300 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
195 | $189 | $650 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
166 | $119 | $550 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
122 | $22 | $150 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
117 | $2 | $15 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
83 | $28 | $100 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $43 | $150 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
72 | $68 | $400 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $11 | $50 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
56 | $110 | $526 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
54 | $64 | $175 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
52 | $20 | $150 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
52 | $30 | $150 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
48 | $187 | $900 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
48 | $48 | $458 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
48 | $141 | $500 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
38 | $46 | $155 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $139 | $600 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $136 | $500 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
26 | $258 | $800 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
26 | $333 | $1,708 |
| Insertion of temporary bladder tube | 25 | $35 | $147 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
22 | $60 | $175 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $92 | $2,858 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
14 | $30 | $125 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
13 | $228 | $584 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
13 | $44 | $300 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
12 | $15 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.4% high complexity
32.0% medium
67.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,516
Total received (2018-2024)
Avg $3,359/year across 7 years
Top 11% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
207
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,452
2023
$8,099
2022
$1,083
2021
$4,687
2020
$4,439
2019
$792
2018
$965
Payments by company (2024)
Boston Scientific Corporation
$2,488
PROCEPT BioRobotics Corporation
$145
Janssen Biotech, Inc.
$114
Olympus America Inc.
$112
Tolmar, Inc.
$102
ABBVIE INC.
$90
Ferring Pharmaceuticals Inc.
$75
180 Medical, Inc.
$56
Dendreon Pharmaceuticals LLC
$34
ACCORD HEALTHCARE, INC.
$27
Antares Pharma, Inc.
$27
Endo USA, Inc.
$24
Teleflex LLC
$24
IMMUNITYBIO, INC.
$22
PROGENICS PHARMACEUTICALS, INC.
$20
PFIZER INC.
$20
Telix Pharmaceuticals
$19
Myriad Genetic Laboratories, Inc.
$18
Astellas Pharma US Inc
$17
Calyxo, Inc.
$16
Top 3 companies account for 79.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$11,969
BOSTON SCIENTIFIC CORPORATION
$4,081
Olympus Medical Systems Corporation
$1,620
PROCEPT BioRobotics Corporation
$1,453
Janssen Biotech, Inc.
$539
Astellas Pharma US Inc
$419
Progenics Pharmaceuticals, Inc.
$293
PFIZER INC.
$273
Antares Pharma, Inc.
$171
Richard Wolf Medical Instruments Corp.
$168
ABBVIE INC.
$167
UROVANT SCIENCES INC
$152
UROGEN PHARMA, INC.
$144
Ferring Pharmaceuticals Inc.
$140
Tolmar, Inc.
$129
180 Medical, Inc.
$126
Olympus America Inc.
$125
Agiliti Surgical, Inc.
$118
Coloplast Corp
$106
NeoTract Inc.
$90
AbbVie Inc.
$90
Medtronic USA, Inc.
$86
UroGen Pharma, Inc.
$78
Dendreon Pharmaceuticals LLC
$74
Myriad Genetic Laboratories, Inc.
$72
TOLMAR Pharmaceuticals, Inc.
$67
Medtronic, Inc.
$67
Telix Pharmaceuticals
$59
KARL STORZ Endoscopy-America
$54
Laborie Medical Technologies Corp.
$54
AbbVie, Inc.
$47
Myovant Sciences Inc.
$44
Allergan, Inc.
$39
Avadel Specialty Pharmaceuticals, LLC
$36
Supernus Pharmaceuticals, Inc.
$29
ACCORD HEALTHCARE, INC.
$27
Endo USA, Inc.
$24
Teleflex LLC
$24
IMMUNITYBIO, INC.
$22
Beckman Coulter, Inc.
$22
Janssen Scientific Affairs, LLC
$21
PROGENICS PHARMACEUTICALS, INC.
$20
IsoRay, Inc
$19
Endo Pharmaceuticals Inc.
$19
Sumitomo Pharma America, Inc.
$19
Sun Pharmaceutical Industries Inc.
$18
Calyxo, Inc.
$16
COLOPLAST CORP
$15
Axonics, Inc.
$15
Blue Earth Diagnostics Limited
$14
E.R. Squibb & Sons, L.L.C.
$14
Merck Sharp & Dohme Corporation
$14
Ambu Inc.
$12
Top 3 companies account for 75.1% of all-time payments
Associated products mentioned in payments ›
24/26 FR. · 8.5 FR. X 700MM · ACCESS 2 · ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Androgel · Axonics · Axumin · BIPOLAR · BOTOX · BRACHYTHERAPY SOURCE · CAMCEVI · CMOS VIDEO URETEROSCOPE · CONTINENCE CARE · CURE CATHETER · CUTTING LOOP · CVAC ASPIRATION SYSTEM · Cristacath · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL ERECTILE DYSFUNCTION · GENERAL - KIDNEY STONE DISEASE · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Moses 550 D\F\L · Myrbetriq · NOCDURNA · Noctiva · OES CHOLEDOCHOFIBERSCOPE · OPDIVO · ORGOVYX · OTREXUP · Olympus Cystoscopes · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SOLYX · SPEEDICATH · Sonablate · SpeediCath · TLANDO · TOVIAZ · UroLift · XIAFLEX · XTANDI · XYOSTED · YONSA · ZYTIGA · bk3000 · bk3500 & bk5000 Ultrasound System · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
13
County median income
$94,452
Nearest hospital to ZIP centroid (approximate)
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kowal is a mixed practice specialist, with above-average Medicare volume (top 3% in MA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kowal experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Kowal performed 4,854 infectious disease dna/rna test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kowal receive payments from pharmaceutical companies?
Yes. Dr. Kowal received a total of $23,516 from 53 companies across 207 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kowal's costs compare to other urology physicians in Hyannis?
Dr. Kowal's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kowal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Hyannis
Browse urology physicians in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Olympus Medical Systems Corporation Payments to Doctors
See all physicians who received payments from Olympus Medical Systems Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology